October 19, 2023
The Texas Therapeutics Institute at UTHealth Houston, led by Zhiqiang An, PhD, is expanding into the Texas Medical Center’s newly completed TMC3 Collaborative Building.
The institute, part of The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases with McGovern Medical School at UTHealth Houston, focuses on antibody drug resistance mechanisms, biomarkers for therapeutic antibodies, and antibody drug discovery targeting human diseases.
October 18, 2023
A five-year, $6.4 million grant to develop an integrated, multiscale artificial intelligence (AI) approach to study genetic factors associated with Alzheimer’s disease has been awarded to UTHealth Houston by the National Institute on Aging, part of the National Institutes of Health.
October 11, 2023
Demetrios Stroubakis, 55, thought he was having a gallbladder attack when he arrived at the emergency room in August 2021 with jaundice. Instead, he was shocked to be diagnosed with pancreatic cancer.
October 6, 2023
The offspring of adolescent and young adult women with a history of cancer face a higher risk of birth defects, according to new research from UTHealth Houston.
October 2, 2023
A four-year, $2.9 million grant to assess the implementation of real-time health intervention to decrease substance use and support HIV prevention strategies in young adults experiencing homelessness, has been awarded to researchers from Cizik School of Nursing at UTHealth Houston by the National Institute of Nursing Research, part of the National Institutes of Health.
October 2, 2023
As one of just six sites in the country chosen for a new consortium of the National Institutes of Health (NIH), UTHealth Houston School of Public Health in Brownsville will use multi-omics in combination with environmental, epidemiologic, and clinical data, along with social determinants of health, to study non-alcoholic and non-viral liver disease in Hispanics/Latinos.
September 29, 2023
A five-year, $3.3 million grant to study symptom management in patients with head and neck cancer has been awarded to researchers from UTHealth Houston by the National Cancer Institute (1R01CA282149), part of the National Institutes of Health.
September 28, 2023
A discovery of a mutation in the gene ACTA2 has given researchers, led by Dianna Milewicz, MD, PhD, with UTHealth Houston, insight into understanding the cause of a rare and progressive problem with arteries in the brain and a cause of strokes in young children, called moyamoya disease.
September 27, 2023
A $2.5 million grant for the transformation of knowledge and treatment of bipolar disorder has been awarded to researchers at UTHealth Houston by Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²).
September 26, 2023
A four-year, $3 million grant to implement and evaluate a multilevel sexual assault and sexual harassment prevention intervention study for active-duty airmen has been awarded to researchers at UTHealth Houston by the U.S. Department of Defense.
